Document is current
Any future updates will be listed below
-
Authors
Gutierrez-Mariscal, Francisco M.
Lopez-Moreno, Alejandro
Torres-Peña, Jose D.
Gomez-Luna, Purificacion
Arenas-de Larriva, Antonio P.
Romero-Cabrera, Juan Luis
Luque, Raul M.
Uribarri, Jaime
Perez-Martinez, Pablo
Delgado-Lista, Javier
Yubero-Serrano, Elena M.
Lopez-Miranda, Jose
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00924937 at ClinicalTrials.govDocuments that mention this clinical trial
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
https://doi.org/10.1186/s12933-023-01933-1
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
https://doi.org/10.1016/j.ahj.2016.04.011
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
https://doi.org/10.1007/s00394-022-03080-x
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
https://doi.org/10.1007/s00394-022-02854-7
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
https://doi.org/10.1007/s00394-021-02676-z
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.120.033214
Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial
https://doi.org/10.1186/s12933-024-02451-4
Sex-specific differences in intestinal microbiota associated with cardiovascular diseases
https://doi.org/10.1186/s13293-024-00582-7
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
https://doi.org/10.1186/s12933-021-01260-3
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/01822)
Consejería de Salud y Familias, Junta de Andalucía (PC-0283-2017)
Ministerio de Ciencia e Innovación (AGL2012-39615)
Fundación Patrimonio Comunal Olivarero (Cordioprev-CEAS, 1/2016)
- License Information
-
More Information
Article History
Received: 21 July 2024
Accepted: 21 September 2024
First Online: 14 October 2024
Declarations
:
: This information is included in the manuscript body.
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
